Using or not using anti-inflammatory drugs against Covid-19: Timeline

Francisco Paraguay-Delgado

doi:10.31531/2581-3080.1000144

Abstract

There is great controversy about the use and non-use of anti-inflammatories during the COVID19 epidemic. From the beginning, the information that has been circulating worldwide presents contradictions. The information from the world health organization (WHO), which presents contradictions on the use of anti-inflammatory drugs, is followed up. The seriousness of these indecisions and their consequences are discussed. It is shown that, due to the indifference to attack this disease in its initial stage, by giving patients only painkillers that mask the advance of COVID-19; by making the patient think that he is healing when in fact his illness is worsening. We include a timeline where the opinions and clinical studies on this subject are observed. Including recent favourable results with the use of anti-inflammatory drugs.

Highlights

There is great controversy about the use and non-use of anti-inflammatories during the COVID19 epidemic
J. et al published in the prestigious Journal the Lancet Infectious Diseases their article “Covid-19: combining antiviral and anti-inflammatory treatments” in which they mentioned that an excessive inflammatory response characterizes both Covid-19 and SARS; In the case of SARS, viral load is not correlated with the worsening symptoms
In the current context of the Covid-19 epidemic infection, the French Minister of Health launched an appeal to warn of the risk of worsening of the infection when taking non-steroidal anti-inflammatory drugs (NSAIDs), including ibuprofen or starting cortisone therapy [18] as on March 16th, 2020

Summary

Introduction

There is great controversy about the use and non-use of anti-inflammatories during the COVID19 epidemic. Different reports have been presented promoting anti-inflammatory drugs for the treatment of Covid-19 disease [1,2]. Discouraging the use of anti-inflammatory drugs is an example of how the authorities make decisions and set guidelines for general treatments in a pandemic.

Results

Conclusion